Skip to main content
. Author manuscript; available in PMC: 2015 Jan 14.
Published in final edited form as: Semin Liver Dis. 2014 Nov 4;34(4):456–464. doi: 10.1055/s-0034-1394144

Fig. 2.

Fig. 2

IL-6/STAT3 signaling and inhibitors. Binding of IL-6 to its receptor activates Janus kinase (JAK) with subsequent phosphorylation, activation, dimerization, and nuclear translocation of STAT3. STAT3 upregulates Mcl-1 transcription. Inhibitors of IL-6, JAK, STAT3, and Mcl-1 are currently in development.